Cesca Therapeutics Inc (KOOL):企業の財務・戦略的SWOT分析

◆英語タイトル:Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15626
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cesca Therapeutics Inc (KOOL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device division, ThermoGenesis Corp. offers the AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. Cesca is headquartered in Rancho Cordova, California, the US.

Cesca Therapeutics Inc Key Recent Developments

Mar 25,2019 Cesca Therapeutics announces fiscal 2018 year end financial results and provides corporate update
Jan 21,2019 ThermoGenesis completes construction and qualification of in-house clean room for assembly of all X-Series cell processing disposables
Nov 19,2018 Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP II AutoXpress Platform for Clinical Cord Blood Banking
Nov 14,2018 Cesca Therapeutics Reports Third Quarter 2018 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cesca Therapeutics Inc – Key Facts
Cesca Therapeutics Inc – Key Employees
Cesca Therapeutics Inc – Key Employee Biographies
Cesca Therapeutics Inc – Major Products and Services
Cesca Therapeutics Inc – History
Cesca Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Cesca Therapeutics Inc – Business Description
R&D Overview
Cesca Therapeutics Inc – Corporate Strategy
Cesca Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Cesca Therapeutics Inc – Strengths
Cesca Therapeutics Inc – Weaknesses
Cesca Therapeutics Inc – Opportunities
Cesca Therapeutics Inc – Threats
Cesca Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Cesca Therapeutics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Cesca Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 25, 2019: Cesca Therapeutics announces fiscal 2018 year end financial results and provides corporate update
Jan 21, 2019: ThermoGenesis completes construction and qualification of in-house clean room for assembly of all X-Series cell processing disposables
Nov 19, 2018: Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP II AutoXpress Platform for Clinical Cord Blood Banking
Nov 14, 2018: Cesca Therapeutics Reports Third Quarter 2018 Financial Results
Oct 16, 2018: Cesca Therapeutics announces cost reduction measures aimed at achieving cash flow positive position in 2019
Sep 30, 2018: Cesca Therapeutics To Announce Financial Results For The Third Quarter Ended September 30, 2018 And Host Conference Call On November 14
Sep 05, 2018: Cesca Therapeutics provides commercialization update for its X-Series product line
Aug 29, 2018: Cesca Therapeutics announces poster presentation at the 4th annual CAR-TCR Summit
Aug 13, 2018: Cesca Therapeutics announces second quarter 2018 financial results and provides corporate update
Jun 04, 2018: Cesca Therapeutics Announces Reduction in Operating Expenses
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cesca Therapeutics Inc, Key Facts
Cesca Therapeutics Inc, Key Employees
Cesca Therapeutics Inc, Key Employee Biographies
Cesca Therapeutics Inc, Major Products and Services
Cesca Therapeutics Inc, History
Cesca Therapeutics Inc, Other Locations
Cesca Therapeutics Inc, Subsidiaries
Cesca Therapeutics Inc, Key Competitors
Cesca Therapeutics Inc, Ratios based on current share price
Cesca Therapeutics Inc, Annual Ratios
Cesca Therapeutics Inc, Annual Ratios (Cont...1)
Cesca Therapeutics Inc, Interim Ratios
Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Cesca Therapeutics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Cesca Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Cesca Therapeutics Inc, Performance Chart (2013 - 2017)
Cesca Therapeutics Inc, Ratio Charts
Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Cesca Therapeutics Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Cesca Therapeutics Inc (KOOL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mochida Pharmaceutical Co Ltd (4534):製薬・医療:M&Aディール及び事業提携情報
    Summary Mochida Pharmaceutical Co Ltd (Mochida) is a pharmaceutical company that develops, manufactures and markets drugs and diagnostic regents. The company's drugs are used for the treatment of arteriosclerosis obliterans, hyperlipidemia, hypertension, angina pectoris, endometriosis, mycosis, thro …
  • SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析
    Summary SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. …
  • Nemus Bioscience Inc (NMUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Nemus Bioscience Inc (Nemus Bioscience) is a life-science and biopharmaceutical company that offers discovering, developing and commercializing cannabinoid-based therapeutics. The company’s drug pipeline products include NB1111, NB1222, NB2111, NB2222 and Cannabinoid platform NB3111. Its can …
  • McDermott International Inc (MDR):石油・ガス:M&Aディール及び事業提携情報
    Summary McDermott International Inc (MII) is a provider of integrated engineering, procurement, construction and installation (EPCI), front-end engineering and design (FEED) and module fabrication services for upstream field developments. It delivers fixed and floating production facilities, pipelin …
  • Zynerba Pharmaceuticals Inc (ZYNE)-製薬・医療分野:企業M&A・提携分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz, Inc., focuses on the development of next-generation synthetic cannabinoid therapeutics. The company’s pipeline product candidates include ZYN002 and ZYN001. Zynerba’s ZYN002 is a synthetic CBD, a non-psychoactive canna …
  • The Kiyo Bank Ltd:企業の戦略・SWOT・財務分析
    The Kiyo Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Kiyo Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Jersey Oil and Gas Plc (JOG):企業の財務・戦略的SWOT分析
    Summary Jersey Oil and Gas Plc (Jersey Oil), formerly Trap Oil Group Plc is an upstream oil and gas exploration and production company. The company acquires, explores, develops and produces natural gas properties in the UK continental shelf. Its oil and gas properties include Homer Block, Cortina Bl …
  • Shinsung Solar Energy Co Ltd (011930)-エネルギー分野:企業M&A・提携分析
    Summary Shinsung Solar Energy Co., Ltd. (Shinsung Solar) is a provider of solar cells. Its products include single-crystalline and multi-crystalline solar cells, and mono-crystalline and multi-crystalline solar panels. Through its subsidiaries, the company offers installment financing, lease financi …
  • University of California Los Angeles-医療機器分野:企業M&A・提携分析
    Summary University of California Los Angeles (UCLA) a subsidiary of University of California is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, graduat …
  • Charter Communications, Inc.:戦略・SWOT・企業財務分析
    Charter Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Charter Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • OncoSec Medical Inc (ONCS)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務情報
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Midland Power Cooperative:発電所・企業SWOT分析
    Midland Power Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • British Airways Plc:企業の戦略・SWOT・財務情報
    British Airways Plc - Strategy, SWOT and Corporate Finance Report Summary British Airways Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • New Zealand Energy Corp (NZ):企業の財務・戦略的SWOT分析
    Summary New Zealand Energy Corp (New Zealand Energy), formerly East Coast Energy Ventures Ltd is an oil and gas company. The company carries out the business of production, development and exploration of conventional and unconventional oil and natural gas prospects in New Zealand. It acquires strate …
  • Breathe Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Breathe Technologies Inc (Breathe Technologies) is a home health care service provider that manufactures and develops innovative medical technologies for patients with respiratory insufficiency and neuromuscular diseases. The company offers research, development and production of new therape …
  • Deutsche Lufthansa AG:企業のM&A・事業提携・投資動向
    Deutsche Lufthansa AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Lufthansa AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • Allightsykes Pty Ltd:企業の戦略・SWOT・財務分析
    Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tech Data Corporation:企業の戦略・SWOT・財務情報
    Tech Data Corporation - Strategy, SWOT and Corporate Finance Report Summary Tech Data Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆